A Phase II Study of Maintenance With Azacitidine in MDS Patients
This study has been terminated.
Sponsor:
Groupe Francophone des Myelodysplasies
Collaborator:
Celgene Corporation
Information provided by (Responsible Party):
Groupe Francophone des Myelodysplasies
ClinicalTrials.gov Identifier:
NCT00446303
First received: March 9, 2007
Last updated: January 18, 2012
Last verified: June 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Study Completion Date: | July 2010 |
| Primary Completion Date: | July 2010 (Final data collection date for primary outcome measure) |